Clinical Trial Update: Efficacy and Safety Study of Sorafenib Plus Pravastatin to Treat Advanced Hepatocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of sorafenib and pravastatin for advanced hepatocarcinoma has completed, reporting efficacy and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Pravastatin (pravastatin)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Hospital Donostia | Conditions: Advanced Hepatocarcinoma | Phase 2 | Status: COMPLETED